MDXG Mimedx Group Inc

Price (delayed)

$11.38

Market cap

$1.27B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.82

Enterprise value

$1.23B

Highlights
The debt has contracted by 27% YoY
The quick ratio has soared by 62% YoY but it has decreased by 2.3% QoQ
Mimedx Group's equity has shrunk by 127% YoY
MDXG's gross profit is down by 17% year-on-year

Key stats

What are the main financial stats of MDXG
Market
Shares outstanding
111.72M
Market cap
$1.27B
Enterprise value
$1.23B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
5.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.01
Earnings
Revenue
$246.47M
EBIT
-$82.23M
EBITDA
-$75.75M
Free cash flow
-$29.82M
Per share
EPS
-$0.82
Free cash flow per share
-$0.27
Book value per share
-$0.07
Revenue per share
$2.25
TBVPS
$1.51
Balance sheet
Total assets
$190.81M
Total liabilities
$106.83M
Debt
$47.8M
Equity
-$8.05M
Working capital
$94.55M
Liquidity
Debt to equity
-5.94
Current ratio
2.71
Quick ratio
2.17
Net debt/EBITDA
0.49
Margins
EBITDA margin
-30.7%
Gross margin
84.2%
Net margin
-35.8%
Operating margin
-15.6%
Efficiency
Return on assets
-46.7%
Return on equity
-1,283.8%
Return on invested capital
-115.3%
Return on capital employed
-60.7%
Return on sales
-33.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MDXG stock price

How has the Mimedx Group stock price performed over time
Intraday
2.43%
1 week
5.37%
1 month
20.42%
1 year
210.93%
YTD
25.33%
QTD
10.49%

Financial performance

How have Mimedx Group's revenue and profit performed over time
Revenue
$246.47M
Gross profit
$207.52M
Operating income
-$38.51M
Net income
-$88.36M
Gross margin
84.2%
Net margin
-35.8%
The operating margin has plunged by 114% YoY but it has grown by 15% from the previous quarter
The operating income has shrunk by 79% YoY but it rose by 15% QoQ
MDXG's gross profit is down by 17% year-on-year
MDXG's revenue is down by 16% YoY

Growth

What is Mimedx Group's growth rate over time

Valuation

What is Mimedx Group stock price valuation
P/E
N/A
P/B
N/A
P/S
5.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.01
Mimedx Group's EPS has decreased by 6% QoQ
Mimedx Group's equity has shrunk by 127% YoY
The P/S is 74% higher than the 5-year quarterly average of 2.9 and 53% higher than the last 4 quarters average of 3.3
MDXG's revenue is down by 16% YoY

Efficiency

How efficient is Mimedx Group business performance
Mimedx Group's return on equity has shrunk by 154% QoQ
Mimedx Group's return on sales has increased by 5% QoQ
MDXG's return on invested capital is up by 3.9% since the previous quarter

Dividends

What is MDXG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MDXG.

Financial health

How did Mimedx Group financials performed over time
The total assets is 79% more than the total liabilities
The quick ratio has soared by 62% YoY but it has decreased by 2.3% QoQ
The current ratio has increased by 49% year-on-year
Mimedx Group's equity has shrunk by 127% YoY
MDXG's debt to equity has soared by 98% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.